3                         SEQUENCE LISTING

<110>  PXD Limited
 
<120>  Biomarkers for Covid-19 Symptom Severity

<130>  P000906.WO

<140>  PCT/GB2021/053084
<141>  2021-11-26

<150>  GB2018922.1
<151>  2020-12-01

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  1

Val Thr Gln Gln Leu Ile Arg Ala Ala Glu Ile Arg Ala Ser Ala 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  2

Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp Pro Gln 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  3

Thr Gln Gln Leu Ile Arg Ala Ala Glu Ile Arg Ala Ser Ala Asn 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  4

Leu Asn Arg Ala Leu Thr Gly Ile Ala Val Glu Gln Asp Lys Asn 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  5

Thr Gln Gln Leu Ile Arg Ala Ala Glu Ile Arg Ala Ser Ala Asn 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  6

Thr Gln Gln Leu Ile Arg Ala Ala Glu Ile Arg Ala Ser Ala Asn 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  7

Thr Gln Gln Leu Ile Arg Ala Ala Glu Ile Arg Ala Ser Ala Asn 
1               5                   10                  15  


